A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague

A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague

Following the deadly anthrax attacks of 2001, the Centers for Disease Control and Prevention (CDC) determined that Bacillus anthracis and Yersinia pestis that cause anthrax and plague, respectively, are two Tier 1 select agents that pose the greatest threat to the national security of the United Sta...

Full description

Bibliographic Details
Main Authors: Pan Tao, Marthandan Mahalingam, Jingen Zhu, Mahtab Moayeri, Jian Sha, William S. Lawrence, Stephen H. Leppla, Ashok K. Chopra, Venigalla B. Rao
Format: Article
Language:English
Published: American Society for Microbiology 2018-10-01
Series:mBio
Subjects:
anthrax vaccine
bacteriophage T4
biodefense
plague vaccine
small outer capsid protein
vaccine delivery
virus nanoparticles
Online Access:https://doi.org/10.1128/mBio.01926-18

Internet

https://doi.org/10.1128/mBio.01926-18

Similar Items